A Randomized Phase II Study of Perioperative mFOLFIRINOX (study drug) versus Gemcitabine/nab-Paclitaxel (study drug) as Therapy for Resectable Pancreatic Adenocarcinoma

BH16-202
Cancer - Pancreatic, Cancer
Chandravathi Loke, MD
D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
Resectable Pancreatic Adenocarcinoma
Betsy Lopez
413-794-4154